- About Us
- Our Research
- Education & Training
- Our Faculty
- Seminars & Events
The Addiction Psychiatry Fellowship Program at the Medical University of South Carolina (MUSC) provides psychiatrists with advanced training in the diagnosis and treatment of addictive disorders and co-occurring psychiatric disorders. Upon successful completion of the one year ACGME-accredited program, graduates will be eligible to test for the ABPN subspecialty board certification in addiction psychiatry. Fellows have access to internationally recognized experts in the field of addiction psychiatry, and the unique opportunity to engage in a variety of research activities that constitute the cutting edge of substance abuse research. The diversity of expertise of our core faculty offers fellows an opportunity to identify particular interest to them and to develop rotations permitting more in-depth knowledge of those areas of interest. Additionally, the MUSC Addiction Psychiatry Fellowship Program offers fellows training in 3 distinctive clinical environments: 1) the Charleston Center, a substance abuse prevention, intervention, education and treatment center; 2) the Ralph H. Johnson VAMC, which proudly serves more than 56,000 Veterans in 21 counties along the South Carolina and Georgia coastline; and 3) the MUSC Medical Center, including inpatient and outpatient experiences.
Eligibility: Individuals must have completed an ACGME accredited psychiatry residency prior to entering the program.
To apply: Please complete the following
For additional questions or concerns, please contact Dr. Tara Wright at email@example.com (preferred mode of contact) or via mail at:
Tara M. Wright, M.D.
Director, Addiction Psychiatry Fellowship Program (MUSC)
Ralph H. Johnson Veterans Affairs Medical Center
Assistant Chief Mental Health Service Line
109 Bee Street
Charleston, SC 29425
MUSC News - Sept 6, 2017
Battling the opioid epidemic - MUSC experts pull together to help stem the tide
Post and Courier News - June 11, 2017
MUSC researchers are recruiting veterans and civilians with PTSD and alcohol addiction for clinical trials